NYB (NYB Holdings) Beneish M-Score


What is NYB Holdings Beneish M-Score?

NYB Holdings does not have enough data to calculate Beneish M-Score.

NYB Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for NYB Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NYB Holdings Beneish M-Score Chart

NYB Holdings Annual Data
Trend Sep24 Sep25
Beneish M-Score
0.00 0.00

NYB Holdings Semi-Annual Data
Sep24 Sep25
Beneish M-Score 0.00 0.00

NYB vs : Beneish M-Score Comparison

For the Biotechnology subindustry, NYB Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NYB Holdings Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NYB Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where NYB Holdings's Beneish M-Score falls into.


NYB Holdings Business Description

Comparable Companies
Address 456 Alexandra Road, No. 04-07, Fragrance Empire Building, Singapore, SGP, 119962
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.